Hepatitis C virus infection and the brain

被引:11
作者
Tillmann, HL [1 ]
机构
[1] Univ Leipzig, Med Klin & Poliklin 2, D-04103 Leipzig, Germany
关键词
hepatitis C; brain; liver; natural history;
D O I
10.1023/B:MEBR.0000043981.89134.39
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While HCV was initially believed to uniformly cause liver inflammation with the consequence of liver cirrhosis in most of the infected patients, prospective studies have shown a much lower than expected rate of cirrhosis in patients infected for more than 20 years. However, a new problem associated with hepatitis C virus infection is emerging. This is the development of sometimes disabling fatigue. While many other viruses of the flaviviridae cause encephalitis, the most closely related virus to HCV in humans, the GB Virus C seems not to be associated with fatigue. Thus the mechanism for the development of fatigue in HCV infection seems specific for HCV. Delineating the mechanism will be a first step to develop treatment option for this currently untreatable impairment.
引用
收藏
页码:351 / 356
页数:6
相关论文
共 29 条
  • [1] DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS
    ALTER, HJ
    PURCELL, RH
    SHIH, JW
    MELPOLDER, JC
    HOUGHTON, M
    CHOO, QL
    KUO, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1494 - 1500
  • [2] THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES
    ALTER, MJ
    MARGOLIS, HS
    KRAWCZYNSKI, K
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    GERBER, MA
    SAMPLINER, RE
    MEEKS, EL
    BEACH, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1899 - 1905
  • [3] Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trial
    Berg, T
    Kronenberger, B
    Hinrichsen, H
    Gerlach, T
    Buggisch, P
    Herrmann, E
    Spengler, U
    Goeser, T
    Nasser, S
    Wursthorn, K
    Pape, GR
    Hopf, U
    Zeuzem, S
    [J]. HEPATOLOGY, 2003, 37 (06) : 1359 - 1367
  • [4] Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
    Bernstein, D
    Kleinman, L
    Barker, CM
    Revicki, DA
    Green, J
    [J]. HEPATOLOGY, 2002, 35 (03) : 704 - 708
  • [5] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362
  • [6] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982
  • [7] Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection
    Goutagny, N
    Fatmi, A
    De Ledinghen, V
    Penin, F
    Couzigou, P
    Inchauspé, G
    Bain, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (12) : 1951 - 1958
  • [8] Griffin D E, 1992, Semin Immunol, V4, P111
  • [9] Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
    Kenny-Walsh, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) : 1228 - 1233
  • [10] 10-year follow-up after interferon-α therapy for chronic hepatitis C
    Lau, DTY
    Kleiner, DE
    Ghany, MG
    Park, Y
    Schmid, P
    Hoofnagle, JH
    [J]. HEPATOLOGY, 1998, 28 (04) : 1121 - 1127